Multidisciplinary Approach to Reduce Cardiovascular Health Disparities

Description

The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke. Participants will engage in laboratory testing and health outcome assessments.

Conditions

Acute Coronary Syndrome, Multi Vessel Coronary Artery Disease, Ischemic Stroke

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke. Participants will engage in laboratory testing and health outcome assessments.

Multidisciplinary Approach to Reduce Cardiovascular Health Disparities in the Baltimore RAcial Minority CommunitiEs (M-BRACE Trial)

Multidisciplinary Approach to Reduce Cardiovascular Health Disparities

Condition
Acute Coronary Syndrome
Intervention / Treatment

-

Contacts and Locations

Baltimore

Sinai Hospital of Baltimore, Baltimore, Maryland, United States, 21215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients ≥18 years of age admitted with ACS, AIS, or multi-vessel CAD
  • * Competent mental condition to provide informed consent and able to participate in follow-ups
  • * Pregnant women
  • * Currently enrolled in an investigational drug or device trial
  • * Undergoing treatment for neoplastic, autoimmune, or connective tissue disease
  • * COVID-19 infection within 30 days of enrollment
  • * Known history of hepatitis or HIV
  • * Deemed unfit to participate according to the investigator
  • * Known history of drug abuse
  • * Known platelet count of \<100,000/mm3
  • * Hematocrit \< 25%

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

LifeBridge Health,

Jenna Brager, PhD, STUDY_CHAIR, LifeBridge Health

Study Record Dates

2025-12